There are only a few scientifically robust mechanistic studies with Lycium fruits, also known as Goji berry, that have addressed preventive or therapeutic intervention of breast cancer. In the present study, we aim to investigate the antiproliferative effects of both Lycium barbarum fruit (Goji berry red fruit) and Lycium ruthenicum (Goji berry black fruit) extracts against triple-negative MDA-MB-231 cells and explore the possible mechanisms of their anticancer effects. IC 50 values were 87.0 and 79.4 µg/mL for goji berry black fruit extract and goji berry red fruit extract, respectively. Pretreatment with both extracts inhibited phosphorylation of epidermal growth factor receptor (EGFR)/extracellular signal-regulated kinases (ERK) in epidermal growth factor-treated MDA-MB-231 cells. The present study also examined whether the phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)/Akt signaling pathway was involved in the regulation of Goji berry extract-induced cell death. Furthermore, treatment with Goji berry fruit extracts inhibited the expression of anti-apoptotic Bcl-2, but enhanced pro-apoptotic Bax expression at transcriptional levels and induced cancer cell apoptosis by activation of pro-apoptotic caspase-9 and caspase 3. Goji berry fruit extracts caused death of MDA-MB-231 breast cancer cells by inhibiting EGFR/ERK-mitogen activated protein kinases (MAPK) and PI3K/Akt signaling pathways. This study suggests that Goji berry fruit extracts might be beneficial for treating triple-negative breast cancer.
Breast cancer is a malignant tumor with the ability to spread beyond the breast tissue. The patients with breast cancer exhibited a high mortality rate, primarily caused by metastasis and invasion of cancer cells [1] . Extensive research has been carried out for subtyping breast cancer at molecular and genetic level and to determine various clinical, pathological and molecular factors for selection of treatment modalities and prognosis of disease during diagnosis. Breast cancers are categorized into three main groups based on cellular markers reflecting available targeted therapies: (a) estrogen receptor (ER)-or progesterone receptor (PR)-positive; (b) human epidermal growth factor receptor 2 (HER2)-positive (amplification of erbB2) with or without ER and PR positivity; and (c) triple-negative breast cancer (TNBC) defined by the absence of ER/PR expression and HER2 amplification [2, 3] .
Both epidermal growth factor receptor (EGFR) HER1 and HER2 belong to the same family and share a high degree of structural and functional homology [4] . EGFR/PI3K/Akt signaling pathway is the major cell survival pathway that plays an important role in cellular metabolism, growth, proliferation, differentiation, and survival. The occurrence of TNBC has been reported to be due to overexpression or mutation of the key proteins involved in this pathway [5] . Amplification of the HER-2 gene occurs in approximately 25% of breast cancers, causing up-regulation of key signaling pathways which control cell growth and survival [6] .
Apoptosis is a coordinated and often energy-dependent process that involves in the activation of a group of cysteine proteases called "caspases" and a complex cascade of events that link the initiating stimuli to the final demise of the cell. There are two main apoptotic pathways: the extrinsic or death receptor pathway and the intrinsic or mitochondrial pathway. The extrinsic signaling pathways that initiate apoptosis involve transmembrane receptor-mediated interactions. The intrinsic signaling pathways that initiate apoptosis involve a diverse array of non-receptor-mediated stimuli that produce intracellular signals that act directly on targets within the cell and are mitochondrial-initiated events. Studies strongly suggested that the loss of apoptotic control in favor of cell proliferation is responsible for breast cancer initiation and progression. Tumor cells do not undergo apoptosis easily because they have defects in their ability to activate the death signaling pathway [7, 8] .
Natural products play a critical role in the discovery and the development of numerous drugs for the treatment of various types of diseases, including cancer [9] . Fruits of Lycium species are mentioned in Chinese materia medica and nowadays has been widely used as popular functional foods with vital biological activities [10] . Numerous health benefits associated with goji berry consumption were attributed to their high content of polysaccharides, carotenoids, polyphenols and other phytochemicals [11, 12] . L. barbarum polysaccharide, (LBP) the main active ingredient of L. barbarum, has multiple biological and pharmacological functions, including neuroprotection, anti-aging, antioxidant, anti-inflammatory and anticancer activities [13, 14] . L. ruthenicum (black goji berry) could be exploited as a functional food [15] . As compared to the red goji berry, the study on black goji berry is limited. It is necessary to compare the differences between red and black goji berry in terms of phytochemical and antioxidant capacities [16] . In the present study, we aim to investigate the antiproliferative effects of both L. barbarum fruit (Goji berry red fruit) and L. ruthenicum (Goji berry black fruit) extracts against triplenegative MDA-MB-231 cells and explore the possible mechanisms of their anticancer effects.
Effects of GBBFE and GBRFE on Proliferation of MDA-MB-231
Cells: MTT assay is a quantitative colorimetric assay for measuring cellular growth, cell survival and cell proliferation based on the ability of living cells. GBBFE and GBRFE at 25 to 150 µg/mL exhibited significant dose-dependent inhibitory effects on the proliferation of MDA-MB-231 cells (Figure 1 ). The concentrations producing 50% growth inhibition (IC 50 ) of the GBBFE and GBRFE on MDA-MB-231 were 87.0 µg/mL and 79.4 µg/mL, respectively whereas the IC50 value of cis-platin was found 33.2 µM as positive control. The MTT assays are endpoint assays and can only detect viable cell at a particular time point. Experiments were carried out using the xCELLigence system (Roche) which offers continual label-free non-invasive analysis of cell proliferation over time. Cell index values of MDA-MB-231 cells were used to examine cell viability. RTCA assay was performed by using 5,000 cells/100 mL per well to monitor the cytotoxicity of GBBFE (25, 50, 100, and 150 µg/mL) and GBRFE (25, 50 , 100, and 150 µg/mL) ( Figure 2 ). According to the cell viability results, 24 h IC 50 of GBBFE was 92.9 µg/m L and 94.7 µg/mL for GBRFE. The mitogen-activated protein kinase (MAPK) pathway is one of the main downstream effectors of EGFR, including the ERK1/2 and p38 MAPK. To determine the effects of GBBFE and GBRFE on the EGFR/MAPK pathway, EGF-induced activation (phosphorylation) of EGFR and downstream system p-ERK1/2 and p-P38MAPK were detected by Western blot at indicated times and various concentrations ( Figure 3 ). Pre-treatment with extracts caused a significant attenuation of EGF-induced phosphorylation of EGFR. Moreover, the activation of ERK1/2 in the GBBFE and GBRFE treatment groups were lower than those in the control group. Interestingly, pre-treatment with GBBFE inhibited the activation of p38/MAPK, but GBRFE pre-treatment induced the activation of P38. The difference between GBBFE and GBRFE in the effect on p38/MAPK signaling is needed to be examined in future.
Effects of GBBFE and GBRFE on PI3K/Akt signaling in vitro on MDA-MB-231 Breast cancer cells:
The MDA-MB-231 cells were cultured and treated with 60 µg/mL, 120 µg/mL GBBFE and 75 µg/mL, 150 µg/mL GBRFE for indicated time periods. The phosphorylated level of PI3K and its downstream protein phosphorylated Akt were detected by Western blotting (Figure 4 ).
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Comparing to the Control Group, the PI3K phosphorylation level of in the MDA-MB-231 cells inhibited with 60 µg/mL, 120 µg/mL GBBFE and 75 µg/mL, 150 µg/mL GBRFE pre-treatments. Similar patterns were also observed in the Akt phosphorylation.
GBBFE and GBRFE induced cellular death by increasing transcriptionally BAX/BCL-2 ratio and cleaved-caspase9/3 protein expressions: To investigate the apoptosis-inducing effects of GBBFE and GBRFE, MDA-MB-231 cells were treated with various concentrations of the extracts. The expression of apoptosisrelated proteins (caspase 9 and caspase 3) was evaluated using Western blot analysis. As shown in Figure 5 , after treatment with GBBFE and GBRFE, expression of caspase 9 and caspase 3 was up-regulated compared to that of control group. Moreover, after treatment with GBBFE, mRNA expression of Bax was significantly up-regulated compared to that of control group. In contrast, the mRNA level of Bcl-2 was markedly down-regulated compared to that of control group, resulting in an obvious increase in the ratio of Bax to Bcl-2. GBRFE treatment increased BAX/BCL-2 ratio, but the difference did not reach the level of statistical significance.
Chemical composition of the extracts:
The chemical compositions of the extracts were determined using high performance liquid chromatography (HPLC) analyses (Table 1) . Gallic acid was identified as the main compound in the L. ruthenicum extract whereas L. barbarum had chlorogenic acid, kaempferol, gallic acid and p-coumaric acid. TNBC is an aggressive and deadly breast cancer subtype with limited treatment options. Nevertheless, TNBC is yet clearly not curable. It is necessary to seek complementary strategies for this breast cancer subtype [17] . Alternate strategies involving traditional herbal medicine in an adjuvant setting may lead to a dose reduction and/or enhanced efficacy of chemotherapeutic agents resulting in a favorable toxicity profile. In the present study, we examined the anticancer effects of goji berry red fruit extract (L. barbarum, GBRFE) and goji berry black fruit extract (L. ruthenicum, GBBFE) and the underlying mechanism in TNBC. The signaling pathways involved in the anticancer effect of goji berry black fruit extract (L. ruthenicum, GBBFE) treatment was also investigated.
It has been shown that the growth-inhibitory effects of GBBFE and GBRFE are attributed to activation of apoptosis. Our results exhibited that the apoptosis induced by GBBFE and GBRFE is accompanied by upregulation of caspase 9 and caspase 3 and also increase in the transcriptional ratio of BAX/BCL-2.
Currently, several studies are concentrating on the antitumor effect of L. barbarum. According to these studies, treatment with ethanolic L. barbarum (Goji berry) extract led to human breast cancer T47D cell apoptosis along with increased in the expression of pro-apoptotic BAX protein, and decreased in the expression of anti-apoptotic BCLxL protein [18] . Similarly, L. barbarum polysaccharides exhibited significant cytotoxic effects against PC-3 and DU-145 human prostate cancer cells by damaging cellular DNA, inducing cell apoptosis, regulating gene expression of Bcl-2/Bax, and also inhibited PC-3 tumor growth in nude mice [19] . In another study, L. barbarum polysaccharides inhibited the proliferation of human cervical carcinoma cells (HeLa) by changing cell cycle distribution and inducing apoptosis. Loss of mitochondrial membrane potential, the increase of intracellular Ca +2 levels and over-production of NO are involved in the induction of apoptosis by L. barbarum polysaccharides in HeLa cells through the mitochondrial pathway [20] . In addition to all these studies, L. europaeum extract led to a loss of cell viability in A549 lung cancer cells. Results showed that after an exposure of few hours to the L. europaeum extract, caspase 3 and caspase 7 enzymes were strongly activated in A549 cells compared to untreated cell [21] .
Endothelial growth factor receptor (EGFR) has been reported to be overexpressed in various types of cancer, including lung [22] , colon [23] and breast cancer [24] . Activation of the EGFR cascades by interacting with ligands activate the downstream system and regulate cancer cell proliferation, survival, adhesion, migration and differentiation [25] . The main downstream effector of EGFR is mitogen-activated protein kinase (MAPK) pathway including the ERK1/2, the JNK/stress-activated protein kinase, and P38 MAPK [26] . A number of studies have demonstrated that the EGFR/MAPK pathway is responsible for proliferation, survival, and metastasis of cancer cells suggesting that identifying the approaches or drugs for inhibiting this pathway might have potential therapeutic value [27, 28] .
In this study, the GBBFE and GBRFE have been shown to induce apoptosis in MDA-MB-231 cells via ERK/MAPK and P38/MAPK signaling pathway. MAPK regulatory effects of goji berry crude extracts and goji berry polysaccharides in cancer cells have not been thoroughly studied. In a previous study, L. barbarum polysaccharide-rich extract caused a growth inhibition of breast cancer MCF-7 cells with the arrest of the cell cycle in S phase and inducted apoptosis through the ERK/MAPK pathway [29] .
The other downstream effector of EGFR is PI3K/Akt signaling pathway. PI3K/AKT signal transduction pathway plays a pivotal role in cell survival and prevents cancer cells from apoptosis during tumorigenesis. Therefore, blockade of the PI3K/Akt pathway has become a cancer therapy strategy [30, 31] . This is also in agreement with our findings that GBBFE and GBRFE impaired the 704 Natural Product Communications Vol. 13 (6) 2018 Cumaoglu et al.
phosphorylation PI3K and Akt, repressing the PI3K/AKT pathway, downregulating Bcl-2, and upregulating Bax, which consequently induced MDA-MB-231 cell death.
The apoptosis inducing effects of goji berry extracts and polysaccharides by downregulating PI3K/Akt activation have been shown in several different cancer cell lines. The results of the previous study have shown that treatment with goji berry polysaccharide-rich extract inhibited the proliferation and migration of bladder cancer cells (BIU87) by, at least partly, repressing PI3k/AKT pathway [32] . In another study, treatment with goji berry polysaccharide reduced the phosphorylation of PI3K and AKT in SGC-7901gastric cancer cells. These results also suggested that goji berry polysaccharide could inhibit the PI3K/AKT/Snail signaling pathway which was involved in epithelial-mesenchymal transition of human gastric cancer cells [33] . In addition to these studies, treatment with L. barbarum water soluble fractions (i.e., L. barbarum phytochemicals) downregulated endoplasmic reticulum stress, modulated multiple signaling pathways, including inhibition of AKT phosphorylation on Ser473 and Thr308, led to inhibition of proliferation and induction of apoptosis in Jurkat Cells [34] . An important mechanism underlying the pharmacological action of goji berry polysaccharide that mediated the inhibition of insulin growth factor-1 (IGF-1)-induced angiogenesis through PI3K/HIF-1a/VEGF signalling pathways have been shown in MCF-7 breast cancer cells [35] .
Gallic acid was the major component of L. ruthenicum extract which might be responsible from the proapoptotic effect supporting the data that gallic acid treatment significantly reduces cell viability of malignant human breast cancer cell line MDA-MB-231 via induction of both G1 phase arrest and apoptosis, which may attribute to the increase of p21 and p27 by activation of p53 [36] .
In conclusion, our present study for the first time demonstrated the anticancer effects of goji berry black fruit extract (L. ruthenicum, GBBFE) and goji berry red fruit extract (GBRFE) against MDA-MB-231 of triple-negative breast cancer cells. Our results showed that the GBBFE and GBRFE inhibited the proliferation of MDA-MB-231 cells, inhibited EGF-induced activation of EGFR and simultaneously triggering ERK/MAPK, repressed PI3K/AKT pathway, which resulted in down-regulation in BCL-2 levels and up regulation in BAX level which consequently induced MDA-MB-231 cell death. Our data support the use of goji berry extracts as complementary medicines for management of triple-negative breast cancer patients.
Experimental
Plant Materials and Extraction Method: L. barbarum L. (red goji berry) and L. ruthenicum Murray (black goji berry) were cultivated at Erciyes University Park and Gardens Directorate (Kayseri, Turkey). The plant material was identified by Assist. Prof. Ayşe Baldemir, from Erciyes University, Turkey. Frozen fruits of red and black goji berries were used to make the methanolic extract.
Crushed material was extracted with methanol at room temperature for three days. Then, the extracts were filtered. The dried extract was stored in refrigerator at −20 ˚C for further studies.
Chromatographic Analysis: Qualitative and quantitative compositions of the extracts were studied using the highperformance liquid chromatography (HPLC) systems (Agilent Tech. 1260, Missis-sauga, ON, Canada). A method, based on Wang et al. [37] , was modified to detect phenolic compounds. Separations were performed on a reversed-phase C18 analytical column (25 x 0.46 cm,5 µm particle size), operating at r.t. (22 °C) at a flow rate of 1 ml/min. A wavelength of 200 -550 nm was used in the detection. Solvent A; 1 % formic acid solution, solvent B; tetrahydrofuran and solvent C; acetonitrile were used the following gradient elution as the mobile phase for the analysis: For 3 min 98% A and 2% B, decreased to 93% A, 2% B, 5% C in 11 min, 76% A, 2% B and 22% C in 20 min., 68% A, 2% B and 30% C in 25 min, 63% A, 2% B and 35% C in 30 min, and returned to 98% A and 2% B in 35 min. Quantitative determinations were performed using an external standard method (R2 > 0.999). The components were identified by comparing their retention times to those of authentic standards under identical analysis conditions and UV spectra using our inhouse diode array detector (PDA) library.
Cell Culture: MDA-MB-231 human metastatic breast cancer cells were obtained from American Type Culture Collection (ATCC HTB-26 ™ , Manassas, VA, USA), and cells were cultured overnight in T-25 cell culture bottle within a final volume of 4 mL RPMI-1640 medium supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 10 µg/mL streptomycin at 37˚C in a humidified chamber of 95% air and 5% CO 2 atmosphere. 
Cell Proliferation

RTCA Cell Viability:
Firstly, optimal seeding concentration of MDA-MB-231 cells were determined and then the cells (5,000 cells/well) were seeded in 96-well E-plate. Cell proliferation, attachment and spreading were monitored every 15 minutes via the impedance of E-plate wells. Approximately 24 h post-seeding when the cells were in the log growth phase, we treated cells with GBBFE and GBRFE at 25, 50, 100, 150 µg/mL concentrations and the experiments were run for about 72 h. Cytotoxic effect of these extracts was monitored with xCELLigence Real-Time Cell Analyzer (RTCA) system as described by the manufacturer's instructions (Roche Applied Science and ACEA Biosciences, San Diego, CA, USA) with slight modifications. IC50 (half maximal inhibitory concentration) values were calculated via RTCAintegrated software of the xCELLigence system at 24 h.
Quantitative-RT-PCR:
MDA-MB-231 cells cultured in 6-well treated with extracts (100 µg/mL) for 6 and 24 h. Total RNA was isolated using RNAzol isolation reagent (Sigma-Aldrich, St. Louis, MO, USA), according to the manufacturer's instructions. Total RNA (1 µg) was reverse-transcribed to cDNA using a Transcriptor High Fidelity cDNA Synthesis Kit (Roche Diagnostics GmbH, Mannheim, Germany). Real-time PCR was carried out using a Light Cycler Nano System (Roche Diagnostics GmbH, Mannheim, Germany). To quantify cDNA, qPCR was performed using FastStart Essential DNA probe master mix (Roche Diagnostics GmbH, Mannheim, Germany) and catalogue assay kit (kits consist mix of primers and probes for determination of Bax and Bcl-2). For each sample the level of target gene transcripts was normalized to β-actin.
Western Blot: After various times and doses treatment protocols, cells were lysed in 250 µL of RIPA lysis buffer (25mM Tris, pH 7,4), 150 mM NaCl, 0.5% sodium deoxycholate, 1% NP-40) supplemented with protease inhibitor cocktail (Complete MiniTM, Roche, Mannheim, Germany) and 1 mM Na 3 VO 4 . Protein concentrations were determined by using the BCA protein assay (Pierce, USA). 30 µg protein lysates were heated for 5 min at 94 C in Laemmli sample buffer containing 4 % β-mercaptoethanol and loaded on 4-12 % Tris-glycine sodium dodecyl sulfate polyacrylamide gel electrophoresis SDS-PAGE gels, then transferred electrophoretically to polyvinylidene fluoride PVDF membranes. Membranes were incubated overnight at 4 C with phospho-EGFR (Tyr 1068), phospho-ERK (Thr202/Tyr204), phospho-P38 (Thr180/Tyr182), phospho-PI3K (p85Try 458/p55Try 199), phospho-Akt (Ser 473), anti-caspase 3, anti-caspase 9 and glyceraldehyde-3-Phosphate dehydrogenase GAPDH (Cell Signaling Technology, USA), Protein bands were detected with horseradish peroxidase-conjugated secondary antibodies (Cell Signaling Technology) and visualized by West-Pico ECL reagents (Pierce).
Statistical Analysis: Possible associations between groups were analyzed with SigmaPlot 12 statistical software using student's ttest. P values <0.05 were considered as statistically significant. Fold increase or decrease of mRNA levels was also calculated by REST (relative expression software tool) software developed for groupwise comparison and statistical analysis of relative expression.
